Related Experiment Video
Updated: Jun 5, 2026

Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
The human microbiome in multiple sclerosis: pathogenic or protective constituents?
Christopher Power1, Joseph M Antony, Kristofor K Ellestad
1Division of Neurology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada.
Abstract:
The human microbiome is comprised of commensal and pathogenic microorganisms, which exert diverse effects in close proximity to the site of intection as well as in remote tissues through immune-mediated mechanisms. Multiple infectious agents have been implicated in the pathogenesis of multiple sclerosis (MS) with variable findings depending on the agent, techniques, and disease phenotype. Herein, the contributions of individual infectious agents to MS and their effects on the immune and nervous systems are reviewed, focusing on herpes viruses, coronaviruses, retroviruses, and synchronic infections. While infectious agents are often assumed to be pathogenic, their effects might also be beneficial to the host in the long-term, depending on age and the type of immunogen/pathogen exposure, as proposed by the hygiene hypothesis. The human microbiome has potential impact on future diagnostic and therapeutic issues in MS.
Insights
The human microbiome influences multiple sclerosis (MS) pathogenesis. Infections may be pathogenic or beneficial, impacting immune and nervous systems, with implications for MS diagnosis and therapy.
Area of Science:
- Microbiology
- Immunology
- Neuroscience
Background:
- The human microbiome comprises microorganisms with diverse effects on host tissues.
- Infectious agents are implicated in multiple sclerosis (MS) pathogenesis, with varied findings.
- The hygiene hypothesis suggests potential long-term benefits of certain microbial exposures.
Purpose of the Study:
- To review the role of specific infectious agents in MS.
- To examine the impact of these agents on the immune and nervous systems.
- To explore the microbiome's potential in MS diagnostics and therapeutics.
Main Methods:
- Literature review focusing on herpes viruses, coronaviruses, and retroviruses.
- Analysis of immune-mediated mechanisms in MS pathogenesis.
- Consideration of synchronic infections and their role.
Main Results:
- Infectious agents' contributions to MS vary based on agent, techniques, and phenotype.
- Effects on immune and nervous systems are diverse, potentially pathogenic or beneficial.
- Microbiome interactions may influence disease course and outcomes.
Conclusions:
- Infectious agents play a complex role in MS, not exclusively pathogenic.
- The human microbiome holds significant potential for future MS diagnostics.
- Targeting the microbiome may offer novel therapeutic strategies for MS.
Related Concept Videos
Introduction to the Human Microbiota
Dysbiosis of the Gut Microbiota
The Skin Microbiota
Multiple Sclerosis l: Introduction
Functions of the Gut Microbiota
The Oral Microbiota

